What is the typical treatment for eczema?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Eczema (Atopic Dermatitis)

Start with topical corticosteroids as first-line therapy, using the least potent preparation that controls symptoms, applied once daily to affected areas, combined with liberal emollient use. 1, 2, 3

First-Line Treatment Algorithm

Topical Corticosteroids: The Cornerstone

  • Apply topical corticosteroids once daily (not twice daily) to affected areas—once daily application is equally effective as more frequent use for potent corticosteroids 4, 5
  • Select potency based on severity and location:
    • Mild eczema: Start with mild-potency topical corticosteroids 3
    • Moderate to severe eczema: Use moderate or potent topical corticosteroids, which are significantly more effective than mild preparations (70% vs 39% treatment success for potent vs mild) 6, 4
    • Very potent corticosteroids: Reserve for limited periods only, with short "steroid holidays" when possible 2
  • Avoid very potent corticosteroids on thin-skinned areas (face, neck, flexures, genitals) where atrophy risk is higher 2
  • Continue topical corticosteroids even when bacterial infection is present, as long as appropriate systemic antibiotics are given concurrently 2

The evidence strongly supports this approach: potent and moderate topical corticosteroids are probably more effective than mild preparations (moderate-certainty evidence), with potent corticosteroids showing a large increase in treatment success (OR 3.71) 6, 4. Importantly, once-daily application is as effective as twice-daily use, reducing unnecessary exposure 4, 5.

Essential Emollient Therapy

  • Apply emollients liberally and regularly, even when eczema appears controlled—this is the cornerstone of maintenance therapy 2, 3
  • Apply emollients after bathing to provide a surface lipid film that retards water loss 1, 3
  • Use soap-free cleansers and avoid alcohol-containing products, as soaps and detergents remove natural skin lipids 1, 2, 3

Managing Pruritus (Itching)

  • Use sedating antihistamines exclusively at nighttime during severe pruritus episodes to help patients sleep through itching 1, 2, 3
  • Large doses may be required in children to achieve adequate symptom control 1
  • Avoid daytime use to prevent sedation 1
  • Do not use non-sedating antihistamines—they have little to no value in atopic eczema and should not be used routinely 1, 2, 3, 5

This recommendation is critical: sedating antihistamines work through their sedative properties, not through histamine blockade, and are only useful for short-term adjuvant therapy during relapses 1. Non-sedating antihistamines lack evidence of benefit and should be dropped from practice 5.

Managing Secondary Bacterial Infection

Watch for these specific signs of bacterial superinfection: increased crusting, weeping, pustules, or failure to respond to topical treatment 1, 2

  • First-line antibiotic: Flucloxacillin for Staphylococcus aureus, the most common pathogen 1, 2, 3
  • Alternative: Erythromycin for penicillin allergy or flucloxacillin resistance 1
  • Use phenoxymethylpenicillin if beta-hemolytic streptococci are isolated 1
  • Do not delay or withhold topical corticosteroids when infection is present—they remain the primary treatment when appropriate systemic antibiotics are given 2

Eczema Herpeticum: A Medical Emergency

Suspect eczema herpeticum if you observe: grouped vesicles, punched-out erosions, or sudden deterioration with fever 1, 2

  • Initiate oral acyclovir immediately early in the disease course 1, 2
  • Use intravenous acyclovir in ill, feverish patients 7, 2

Proactive (Weekend) Therapy to Prevent Flares

  • Apply topical corticosteroids twice weekly (weekend therapy) to previously affected areas after initial control is achieved 4
  • This approach probably results in a large decrease in likelihood of relapse from 58% to 25% (RR 0.43, moderate-certainty evidence) 4

When to Escalate to Systemic Therapy

Systemic corticosteroids have a limited but definite role only for occasional patients with severe atopic eczema who have failed all other treatments. 7, 1, 2, 3

Critical Restrictions on Oral Steroids

  • Never use for maintenance treatment until all other avenues have been explored 7, 1, 2, 3
  • Try to avoid during acute crises—they should only "tide over" occasional patients 7, 2
  • Significant risks include: pituitary-adrenal suppression and possible interference with growth in children 1, 2

Other Second-Line Options

  • Narrow band ultraviolet B (312 nm) phototherapy for moderate-to-severe disease 7, 2
  • Newer agents (azathioprine, cyclosporin) remain experimental 7

Common Pitfalls to Avoid

  • Steroid phobia leads to undertreatment—explain different potencies and benefits/risks clearly to patients and parents 2
  • Do not apply topical corticosteroids more frequently than recommended—this doesn't improve efficacy but increases side effect risk 3
  • Tachyphylaxis develops with prolonged antihistamine use, progressively reducing effectiveness 1
  • Do not use topical corticosteroids continuously without breaks—implement "steroid holidays" when possible 2

Safety Profile of Topical Corticosteroids

Short-term use (median 3 weeks) of topical corticosteroids does not increase skin thinning risk, even with very potent preparations (low-certainty evidence) 6, 4. Only 26 cases of abnormal skin thinning were identified from 2266 participants across 22 trials (1%), with most cases from higher-potency preparations 4. However, longer-term use (6-60 months) showed increased skin thinning with mild to potent topical corticosteroids versus topical calcineurin inhibitors 6.

When to Refer to a Specialist

  • Failure to respond to moderate potency topical corticosteroids after 4 weeks 2
  • Need for systemic therapy or phototherapy 2
  • Suspected eczema herpeticum (medical emergency) 2
  • Failure to respond to first-line management 7

Adjunctive Measures

  • Keep nails short to minimize scratching damage 1, 3
  • Avoid irritant clothing (wool)—wear cotton next to skin 1
  • Avoid temperature extremes 1
  • Consider dietary trial only when patient history strongly suggests specific food allergy or when widespread active eczema fails first-line treatment 7, 1

Treatments to Avoid

  • Evening primrose oil: No conclusions can be drawn from available data, with two large trials showing no benefit 7
  • Chinese herbal medicines: Hepatotoxicity has been reported; if patients wish to try, advise regular liver function tests 7
  • House dust mite eradication: Evidence for benefits is not strong, and no effective measures for complete eradication currently exist 7

budget:budget_used 8947 7622 1325 0.04486

References

Guideline

Management of Eczema with Oral Treatments

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Eczema (Atopic Dermatitis)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Eczema: Treatment Options and Dosages

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Strategies for using topical corticosteroids in children and adults with eczema.

The Cochrane database of systematic reviews, 2022

Research

Topical anti-inflammatory treatments for eczema: network meta-analysis.

The Cochrane database of systematic reviews, 2024

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.